Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

RNS - Strong Nordic presence: UnoMeterT SafetiT Plus wins tenders in Stockholm and Helsinki/Tampere; footprint established in Denmark with continuous growth

Company: Observe Medical Date: 2025-06-26 Language: English Register to download

Loading document preview...

Document Preview Not Available

The file type (.html) cannot be displayed directly here.

Open Original File

Error loading document preview. Please try the 'Open Original File' link.

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:

Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon

 Strong Nordic presence: UnoMeterT SafetiT Plus wins tenders in Stockholm and Helsinki/Tampere; footprint established in Denmark with continuous growth

# Strong Nordic presence: UnoMeterT SafetiT Plus wins tenders in Stockholm and Helsinki/Tampere; footprint established in Denmark with continuous growth

Oslo, June 24, 2025 - Observe Medical ("the Company" or "Observe Medical") is  

pleased to announce that UnoMeter\[TM\] Safeti\[TM\] Plus has been appointed  

exclusive winner of the tender in the largest region in Sweden, representing  

approximately 20% of the total Swedish market. In Finland UnoMeter\[TM\]  

Safeti\[TM\] has been awarded the tender for Helsinki and Tampere which represents  

approx. 20% of the Finnish market, on a non-exclusive basis. In Denmark supply  

contracts has been signed and deliveries have commenced to 3 out of 5 healthcare  

regions, representing nearly 60% of the national market.  

  

These market penetration activities and tenders were skillfully managed by  

Vingmed which is the Company's distribution partner for the Nordic region and is  

a reflection of the markets desire to get back to the quality level that  

UnoMeter\[TM\] Safeti\[TM\] Plus offers.  

  

Historically the market share of UnoMeter\[TM\] Safeti\[TM\] Plus has been very high  

in the Nordic region and the market represents a market potential of approx. 40+  

mill. NOK. in annual recurring revenue.  

  

Jørgen Mann, CEO of Observe Medical, commented: "Winning major tenders and  

signing significant supply contracts in the Nordic region that historically has  

been a very strong home region, due to the legacy going back to company  

Unomedical which was based in Denmark, is another verification that no  

competitor has been able to replace UnoMeter\[TM\] Safeti\[TM\] Plus as the  

reference point for high quality and clinical performance".  

  

For further information, please contact:  

  

Jørgen Mann, CEO Observe Medical  

Mobile: +45 408 67558  

E-mail: jorgen.mann@observemedical.com  

  

Johan Fagerli, CFO Observe Medical  

Mobile: +47 958 12765  

E-mail: johan.fagerli@observemedical.com  

  

About Observe Medical  

  

Observe Medical is a Nordic medtech company that develops, markets and sells  

innovative medtech products for the global market. The Company is committed to  

improving patient welfare and patient outcomes, improving clinical data accuracy  

and promoting positive health economics.  

  

The Company seeks to drive growth by leveraging its expertise in sales and  

commercialization of its broad portfolio of medical technology products, mainly  

in urine measurement and ultrasound, in combination with targeted M&A and  

distribution. Observe Medical is working with a network of leading distributors  

to provide outstanding solutions for healthcare professionals globally.  

  

The Company is headquartered in Oslo, Norway.  

  

Further information is available atwww.observemedical.com.

Unlock Europe's Largest Financial Database—Free

Get instant access to over 2.8M filings from 8,970 companies across 44 markets. No cost. No hassle. Just results.